Insulet (PODD) Misses Q2 EPS by 14c, Sales Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Insulet Reports Second Quarter 2015 Financial Results
August 12, 2015 4:01 PM EDTBILLERICA, Mass., Aug. 12, 2015 /PRNewswire/ -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced financial results for the three months ended June 30, 2015.       Â
Second Quarter Highlights and Recent Developments:
Second quarter financial results: Total revenue of $75.6 million exceeds Company's prior expectations of $67 to $70 million. U.S. OmniPod revenue of $44.7 million. International OmniPod revenue of $7.7 million. Drug Delivery revenue of $7.5 million. Neighborhood Diabetes revenue of $15.7 million. Announced today appointment of Michael... More